A recent study shows that the histone deacetylase inhibitors (HDACi) SAHA epigenetically upregulates MICA expression through regulating the expression of miR-17-92 cluster and MCM7 in hepatoma. Here, MCM7 is linked to hepatocellular carcinoma.